237 related articles for article (PubMed ID: 34899741)
1. SMAC Mimetics as Therapeutic Agents in HIV Infection.
Molyer B; Kumar A; Angel JB
Front Immunol; 2021; 12():780400. PubMed ID: 34899741
[TBL] [Abstract][Full Text] [Related]
2. DIABLO/SMAC mimetics selectively kill HIV-1-infected resting memory CD4
Campbell GR; Spector SA
Autophagy; 2019 Apr; 15(4):744-746. PubMed ID: 30653393
[TBL] [Abstract][Full Text] [Related]
3. SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells.
Campbell GR; Bruckman RS; Chu YL; Trout RN; Spector SA
Cell Host Microbe; 2018 Nov; 24(5):689-702.e7. PubMed ID: 30344003
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells.
Campbell GR; Zhuang J; Zhang G; Landa I; Kubiatowicz LJ; Dehaini D; Fang RH; Zhang L; Spector SA
Theranostics; 2021; 11(18):9009-9021. PubMed ID: 34522224
[TBL] [Abstract][Full Text] [Related]
5. Smac mimetics as new cancer therapeutics.
Chen DJ; Huerta S
Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
[TBL] [Abstract][Full Text] [Related]
6. Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.
Kim Y; Anderson JL; Lewin SR
Cell Host Microbe; 2018 Jan; 23(1):14-26. PubMed ID: 29324227
[TBL] [Abstract][Full Text] [Related]
7. BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.
Pache L; Dutra MS; Spivak AM; Marlett JM; Murry JP; Hwang Y; Maestre AM; Manganaro L; Vamos M; Teriete P; Martins LJ; König R; Simon V; Bosque A; Fernandez-Sesma A; Cosford ND; Bushman FD; Young JA; Planelles V; Chanda SK
Cell Host Microbe; 2015 Sep; 18(3):345-53. PubMed ID: 26355217
[TBL] [Abstract][Full Text] [Related]
8. Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages.
Caballero RE; Dong SXM; Gajanayaka N; Ali H; Cassol E; Cameron WD; Korneluk R; Tremblay MJ; Angel JB; Kumar A
Sci Rep; 2021 Nov; 11(1):22901. PubMed ID: 34824340
[TBL] [Abstract][Full Text] [Related]
9. SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages.
Campbell GR; To RK; Zhang G; Spector SA
Cell Death Dis; 2020 Jul; 11(7):590. PubMed ID: 32719312
[TBL] [Abstract][Full Text] [Related]
10. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
Zhu H; Li Y; Liu Y; Han B
ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
[TBL] [Abstract][Full Text] [Related]
11. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
13. Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer.
Nikkhoo A; Rostami N; Hojjat-Farsangi M; Azizi G; Yousefi B; Ghalamfarsa G; Jadidi-Niaragh F
J Cell Biochem; 2019 Jun; 120(6):9300-9314. PubMed ID: 30506843
[TBL] [Abstract][Full Text] [Related]
14. Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
Wu MS; Wang GF; Zhao ZQ; Liang Y; Wang HB; Wu MY; Min P; Chen LZ; Feng QS; Bei JX; Zeng YX; Yang D
Mol Cancer Ther; 2013 Sep; 12(9):1728-37. PubMed ID: 23699656
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs
Pache L; Marsden MD; Teriete P; Portillo AJ; Heimann D; Kim JT; Soliman MSA; Dimapasoc M; Carmona C; Celeridad M; Spivak AM; Planelles V; Cosford NDP; Zack JA; Chanda SK
Cell Rep Med; 2020 Jun; 1(3):100037. PubMed ID: 33205060
[TBL] [Abstract][Full Text] [Related]
16. SMAC mimetics as potential cancer therapeutics in myeloid malignancies.
Boddu P; Carter BZ; Verstovsek S; Pemmaraju N
Br J Haematol; 2019 Apr; 185(2):219-231. PubMed ID: 30836448
[TBL] [Abstract][Full Text] [Related]
17. Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells
Jansen J; Kroeze S; Man S; Andreini M; Bakker J-W; Zamperini C; Tarditi A; Kootstra NA; Geijtenbeek TBH
Microbiol Spectr; 2024 Jan; 12(1):e0318023. PubMed ID: 38051053
[TBL] [Abstract][Full Text] [Related]
18. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
Ali R; Singh S; Haq W
Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
[TBL] [Abstract][Full Text] [Related]
19. The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy.
Michie J; Kearney CJ; Hawkins ED; Silke J; Oliaro J
Cells; 2020 Jan; 9(1):. PubMed ID: 31947615
[TBL] [Abstract][Full Text] [Related]
20. Identification of Smac mimetics as novel substrates for p-glycoprotein.
Hugle M; Czaplinski S; Habermann K; Vogler M; Fulda S
Cancer Lett; 2019 Jan; 440-441():126-134. PubMed ID: 30312727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
